Hepatitis B Serology for NEET PG: Marker-by-Marker Interpretation and the Window Period

Hepatitis B serology questions rarely ask you to recall a marker in isolation. They give you a pattern of positives and negatives and ask what it means: acute infection, chronic infection, past infection, vaccination, or the awkward gap in between. If you can name what each marker is a sign of, every pattern becomes a short piece of reasoning.

This post takes each marker in turn, then puts them together in an interpretation table, explains the window period, and ends with the traps examiners like. Most interpretation rows follow the CDC's 2023 testing recommendations, with supporting detail from a 2020 review of hepatitis B diagnosis and treatment and the WHO hepatitis B fact sheet.

Key Takeaways

• HBsAg means current infection (acute or chronic). Chronic infection is HBsAg present for at least 6 months.

• Anti-HBs alone means vaccine immunity (10 mIU/mL or more). Anti-HBs together with total anti-HBc means recovery from natural infection.

• Total anti-HBc appears in every infection, current or resolved, and never from the vaccine. IgM anti-HBc points to recent infection, within less than 6 months.

• Window period: HBsAg has gone, anti-HBs has not yet appeared, and IgM anti-HBc is the only serological evidence of infection.

• HBV DNA is detectable before HBsAg appears and in HBsAg-negative occult infection.

• Isolated anti-HBc has five possible explanations, so it needs context before you label it.

What Each Hepatitis B Serology Marker Tells You

Think of the markers as two groups: antigens (the virus itself) and antibodies (the host response). The antigens are HBsAg and HBeAg. The antibodies are anti-HBs, total anti-HBc, IgM anti-HBc and anti-HBe. HBV DNA is a separate, direct measure of virus in the blood.

A memory aid (our own, not from a guideline): S is for Status, C is for Contact. The surface markers (HBsAg, anti-HBs) tell you the current status: infected, or protected. The core antibody (anti-HBc) tells you about contact: has this person ever met the virus?

HBsAg: the marker of current infection

HBsAg is the hepatitis B surface antigen. Its presence indicates HBV infection, either acute or chronic, according to the CDC 2023 screening and testing recommendations. The one exception is brief positivity after a hepatitis B vaccine dose, reported up to 18 days after vaccination.

Duration separates acute from chronic. HBsAg persisting for at least 6 months defines chronic infection. In a typical acute infection, HBsAg appears about 6 weeks after exposure (range 1 to 10 weeks), and the incubation period is about 90 days (range 60 to 150), per the 2020 diagnosis and treatment review.

Anti-HBs: recovery or vaccination

Anti-HBs is the antibody to the surface antigen, and it is the protective antibody. When it appears after HBsAg declines, it indicates recovery. After vaccination, a level of 10 mIU/mL or more, measured 1 to 2 months after the full series, indicates immunity (CDC 2023; the same cut-off appears in the Australian Prescriber 2026 update).

Two nuances matter. Anti-HBs can wane below 10 mIU/mL in vaccine responders, though most remain immune. And hepatitis B immunoglobulin (HBIG) supplies anti-HBs for 4 to 6 months, so a titre measured within 6 months of HBIG does not reflect the person's own immune status.

Total anti-HBc: proof of contact

Total anti-HBc develops in all HBV infections, resolved or current, and typically persists for life. The vaccine contains only surface antigen, so vaccine-derived immunity never produces anti-HBc. That is why anti-HBs plus anti-HBc means natural infection, while anti-HBs alone means vaccination.

Total anti-HBc assays detect both IgM and IgG. No IgG-only test is commercially available, which is why the report says "total".

IgM anti-HBc: the recent-infection marker

IgM anti-HBc positivity indicates recent infection, within less than 6 months (CDC clinical testing page). The CDC advises ordering it only when acute infection is a concern.

There is a catch. IgM anti-HBc may also be positive during severe flares or reactivation of chronic infection. So IgM positivity does not prove the infection is new. HBsAg status for more than 6 months is what establishes chronicity.

HBeAg and anti-HBe: replication and infectivity

HBeAg marks active viral replication and high infectivity. Anti-HBe is used to monitor treatment response and disease progression, and its presence suggests low-level replication (2020 review).

The same review divides chronic infection into phases by HBeAg status: HBeAg-positive infection, HBeAg-positive hepatitis, HBeAg-negative infection, HBeAg-negative hepatitis, and an HBsAg-negative stage. For NEET PG, the key idea is simple: HBeAg positive means more replication and more infectivity.

HBV DNA: the direct viral load

HBV DNA measures viral load and helps assess infectivity, disease progression and treatment response. It becomes detectable before HBsAg, so it can identify infection during the window period, and it is the test that rules occult infection in or out. The 2020 review recommends real-time PCR with a detection limit of 10 IU/mL.

Marker Roles at a Glance

Use this table to revise what each test is for before you move to patterns.

Marker	What it indicates	Does the vaccine produce it?
HBsAg	Current infection, acute or chronic	No (brief transient positivity possible after a dose)
Anti-HBs	Immunity (recovery or vaccination)	Yes
Total anti-HBc	Any past or current infection	No
IgM anti-HBc	Recent infection, within less than 6 months	No
HBeAg	Active replication, high infectivity	No
Anti-HBe	Lower replication; used to monitor treatment and progression	No
HBV DNA	Viral load; occult infection; window-period detection	No

Hepatitis B Serology Interpretation Table

Read the pattern from left to right: HBsAg first (infected now?), then anti-HBs (protected?), then anti-HBc (ever exposed?), then IgM (recent?). The first six rows follow CDC 2023 Table 1, with the CDC clinical page and the Australian Prescriber update agreeing. The seventh row (window period) comes from the 2020 diagnosis and treatment review.

Pattern	HBsAg	Anti-HBs	Total anti-HBc	IgM anti-HBc	Interpretation
Susceptible, never infected	Negative	Negative	Negative	Negative	Never infected; offer vaccine
Vaccinated	Negative	Positive (10 mIU/mL or more)	Negative	Negative	Immune by vaccination
Resolved infection	Negative	Positive	Positive	Negative	Immune by natural exposure; counsel on reactivation risk
Acute infection	Positive	Negative	Positive	Positive	Acute hepatitis B
Chronic infection	Positive	Negative	Positive	Negative	Chronic hepatitis B (IgM may turn positive in flares)
Isolated anti-HBc	Negative	Negative	Positive	Negative	Depends on cause (see below)
Window period	Negative	Negative	Positive	Positive	IgM anti-HBc is the only serological evidence of infection

The acute-infection pattern can also be seen in chronic hepatitis B during a flare. To tell the two apart, the Australian Prescriber update advises repeating serology 6 months after an acute infection to see whether HBsAg has cleared.

Worked reasoning: three quick patterns

Pattern one: HBsAg negative, anti-HBs positive, anti-HBc negative. There is protection but no contact with the virus, so this is vaccination.

Pattern two: HBsAg negative, anti-HBs positive, anti-HBc positive. The person met the virus and cleared it. Anti-HBs alone could not distinguish this from vaccination, and anti-HBc is what settles it.

Pattern three: HBsAg positive, anti-HBc positive, IgM negative, anti-HBs negative. HBsAg is present with a core antibody that is not IgM, which fits chronic infection.

The Window Period in Hepatitis B Serology

The window period is the gap in which HBsAg has disappeared but anti-HBs has not yet appeared. During this gap, a surface-marker-only screen looks entirely negative, even though the person has just had an acute infection. IgM anti-HBc is the only serological evidence of infection at that point (2020 diagnosis and treatment review).

The review's definition is the basis for the "window period" row in the table above. The CDC does not tabulate this row separately, and no source gives a standard duration, so treat it as a stage in the sequence rather than a fixed number of weeks.

Why the window period matters in practice

Someone who is HBsAg negative and anti-HBs negative in this gap could be mistaken for a susceptible person. The tell is the antibody to the core: anti-HBc will be positive, and so will the IgM fraction. If a question gives you negative surface markers but positive IgM anti-HBc, think of the window period.

HBV DNA offers a second route to the diagnosis. Because it becomes detectable before HBsAg appears, it can pick up infection that surface markers miss. A Virology Journal 2021 paper describes it as common for HBV DNA to remain detectable for about 10 days after HBsAg clearance (a "second window period"), but treat that as an observation, not a rule to memorise.

Isolated Anti-HBc and Occult Hepatitis B

An isolated anti-HBc result (HBsAg negative, anti-HBs negative, total anti-HBc positive, IgM negative) is not one diagnosis. The CDC lists five possible explanations:

1. Anti-HBs has waned after a past infection.
2. Occult infection.
3. Passive transfer to an infant born to an HBsAg-positive parent.
4. A false-positive result.
5. A mutant HBsAg strain that the assay does not detect.

Occult HBV infection (OBI) is defined as replication-competent HBV DNA in the liver or blood of a person who tests HBsAg negative (Lancet Gastroenterology & Hepatology 2022). Anti-HBc is a poor surrogate for it. In that pooled analysis, anti-HBc had a sensitivity of 77% (95% CI 62 to 88) and specificity of 76% (68 to 83) for OBI.

The same analysis found a pooled OBI prevalence of 9.9% among HBsAg-negative, anti-HBc-positive people, against under 0.1% in unselected HBsAg-negative people. These two figures come from different groups of studies, so they are not a like-for-like comparison. Anti-HBc positivity raises the odds, but HBV DNA is what confirms OBI.

Reactivation risk after past infection

A person with past infection (HBsAg negative, anti-HBc positive) can reactivate during significant immunosuppression. The Australian Prescriber update notes that such people may need prophylactic antiviral therapy, irrespective of anti-HBs titre. This is why the resolved-infection row carries the note "counsel on reactivation risk".

Vaccination and the Serology Picture

Vaccination produces only anti-HBs. A vaccinated person is therefore HBsAg negative, anti-HBc negative and anti-HBs positive. The WHO fact sheet recommends the first dose as soon as possible after birth (within 24 hours), and notes that boosters are not usually required after completing the three-dose series.

In India, the schedule follows the same principle: a birth dose within 24 hours, then three pentavalent doses. The full age-wise schedule is covered in our immunization schedule guide.

Common Exam Traps in Hepatitis B Serology

A few patterns account for most wrong answers, and each has a one-line fix.

• Anti-HBs positive does not always mean vaccinated. Check anti-HBc. If it is positive, the immunity came from natural infection.
• IgM anti-HBc positive does not always mean new infection. It can be positive in flares of chronic disease.
• HBsAg negative does not exclude infection. Think window period and occult infection, and remember HBV DNA.
• A negative HBsAg with positive anti-HBc and nothing else is not automatically "past infection". The CDC lists five possibilities.
• Chronic means HBsAg for at least 6 months, not just "HBsAg positive with IgG anti-HBc".

If you want the clinical side of viral hepatitis, our jaundice types guide places hepatocellular jaundice in context. To test yourself on serology patterns, try the virology practice questions.

Conclusion

Hepatitis B serology becomes manageable when you assign one job to each marker: HBsAg for current infection, anti-HBs for immunity, total anti-HBc for any contact, IgM anti-HBc for recent infection, HBeAg for infectivity and HBV DNA for the virus itself. Read patterns in that order and the table rows follow naturally.

The window period is the one place where surface markers fail you. Remember that IgM anti-HBc is the lone positive, and that HBV DNA can bridge the gap.